Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure

Andrew E Farabaugh1, Lisa M Freeman, John E Rush

  • 1Tufts University School of Veterinary Medicine, North Grafton, MA, USA.

Insights

Congestive heart failure (CHF) in dogs alters key immune cells and blood counts. Dogs with CHF showed lower CD4+ and CD8+ lymphocytes, hematocrit, and hemoglobin, but higher leukocytes, neutrophils, and platelets compared to healthy dogs.

Area of Science:

  • Veterinary Medicine
  • Immunology
  • Cardiology

Background:

  • Heart failure is associated with immune system changes in humans.
  • Limited data exists on hematologic and immunologic alterations in dogs with congestive heart failure (CHF).

Purpose of the Study:

  • To compare flow cytometric and hematologic variables in dogs with CHF against healthy controls.
  • To identify specific alterations in lymphocyte subpopulations and complete blood count parameters in canine CHF.

Main Methods:

  • Flow cytometry was used to analyze CD4+ peripheral blood mononuclear cells (PBMC) and CD8+ lymphocytes.
  • Complete blood counts determined white blood cell count, platelet count, hematocrit, and hemoglobin.
  • Twenty-five dogs with CHF (ISACHC class 2 and 3a) and 13 healthy controls were studied.

Main Results:

  • Dogs with CHF exhibited significantly lower percentages of CD4+ PBMC, CD8+ lymphocytes, hematocrit, and hemoglobin.
  • Leukocyte, neutrophil, and platelet counts were significantly higher in dogs with CHF compared to controls.
  • No significant differences in these variables were observed between dogs with dilated cardiomyopathy and chronic valvular disease.

Conclusions:

  • Canine congestive heart failure is associated with significant alterations in CD4+ and CD8+ lymphocyte subpopulations and various blood cell parameters.
  • These hematologic and immunologic changes in dogs with CHF warrant further investigation for clinical implications.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...